<DOC>
<DOCNO>EP-0639644</DOCNO> 
<TEXT>
<INVENTION-TITLE>
New macrolides and their use.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3170	A61K3170	A61K317042	A61K317042	A61K317048	A61P300	A61P300	A61P1900	A61P1910	A61P4300	A61P4300	C07D40700	C07D40706	C07D40714	C07H1700	C07H1704	C07H1708	C12P1702	C12P1708	C12P1900	C12P1958	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07H	C07H	C07H	C12P	C12P	C12P	C12P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61P3	A61P3	A61P19	A61P19	A61P43	A61P43	C07D407	C07D407	C07D407	C07H17	C07H17	C07H17	C12P17	C12P17	C12P19	C12P19	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds of the formula 
<
IMAGE
>
 in which R1 is hydroxyl, 2-hydroxyethoxy, C1-C4-alkoxy, C1-C4-alkanoyloxy, halogen, amine, azide, a keto, p-nitrobenzenesulphonyl or a pyranyloxy group of the formula 
<
IMAGE
>
  in which X is a group of the formula 
<
IMAGE
>
  or 
<
IMAGE
>
 in which R3 is hydroxyl, C1-C4-alkanoyloxy or organic sulphonyloxy, and R4 is hydroxyl or carbamoyloxy, R2 is hydrogen, hydroperoxy, hydroxyl or methoxy, Y is a group of formula 
<
IMAGE
>
  or 
<
IMAGE
>
 in which R5 is hydroxyl or C1-C4-alkanoyloxy, and R6 and R7 are independently of one another, hydrogen or methyl, are suitable for the production of a drug for the prophylaxis and treatment of diseases which respond to inhibition of the osteoclast proton pump.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
CIBA GEIGY AG
</APPLICANT-NAME>
<APPLICANT-NAME>
CIBA-GEIGY AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BINDSEIL KAI UWE DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BODDIEN CLAUDIA
</INVENTOR-NAME>
<INVENTOR-NAME>
ZEECK AXEL PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BINDSEIL, KAI UWE, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
BODDIEN, CLAUDIA
</INVENTOR-NAME>
<INVENTOR-NAME>
ZEECK, AXEL, PROF. DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
